Proteasome inhibitor-induced apoptosis of glioma cells involves the processing of multiple caspases and cytochrome c

B Wagenknecht1, M Hermisson, P Groscurth

  • 1Laboratory of Molecular Neuro-Oncology, Department of Neurology, University of Tübingen, School of Medicine, Tübingen, Germany.

Journal of Neurochemistry
|November 18, 2000
PubMed

Insights

Proteasome inhibitors induce apoptosis in malignant glioma cells via caspase activation and mitochondrial pathways. This cell death is regulated by Bcl-2, XIAP, and caspase activity, but not death ligand signaling.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Oncology

Background:

  • The proteasome is crucial for intracellular protein degradation in eukaryotes.
  • Malignant gliomas are aggressive brain tumors with limited treatment options.

Purpose of the Study:

  • To investigate the mechanisms of apoptosis induced by proteasome inhibitors in human malignant glioma cells.
  • To elucidate the role of caspases, Bcl-2, XIAP, and mitochondrial pathways in this process.

Main Methods:

  • Treatment of human malignant glioma cells with proteasome inhibitors (MG132, lactacystin).
  • Assessment of apoptosis using caspase activation, morphological changes, and mitochondrial membrane potential.
  • Inhibition studies using ectopic expression of XIAP and Bcl-2, and caspase inhibitors (zVAD-fmk, crm-A).

Main Results:

  • Proteasome inhibitors trigger apoptosis involving caspases 2, 3, 7, 8, and 9.
  • Apoptosis is inhibited by XIAP, Bcl-2, and cycloheximide, but not by crm-A.
  • Cytochrome c release and mitochondrial membrane potential disruption are key events, with Bcl-2 being a potent inhibitor.
  • Specific morphological alterations are independent of broad-spectrum caspase inhibition.

Conclusions:

  • Proteasome inhibition induces apoptosis in malignant glioma cells through caspase-dependent and mitochondrial pathways.
  • Bcl-2 and XIAP play significant roles in regulating this apoptotic process.
  • Cytochrome c release occurs upstream of XIAP- and crm-A-sensitive caspases, suggesting a complex regulatory network.

Related Concept Videos

Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...
Phagocytosis of Apoptotic Cells01:17

Phagocytosis of Apoptotic Cells

Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or  immature dendritic cells. Non-professional phagocytes such as  epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes. 
Normal cells contain receptors that prevent them from being recognized by phagocytes.